高级检索
    何勇, 王涵敏. FLAURA研究OS阳性结果——奥希替尼一线治疗晚期EGFR敏感突变非小细胞肺癌[J]. 循证医学, 2020, 20(1): 35-38. DOI: 10.12019/j.issn.1671-5144.2020.01.008
    引用本文: 何勇, 王涵敏. FLAURA研究OS阳性结果——奥希替尼一线治疗晚期EGFR敏感突变非小细胞肺癌[J]. 循证医学, 2020, 20(1): 35-38. DOI: 10.12019/j.issn.1671-5144.2020.01.008
    shu
    HE Yong, WANG Han-min. Overall Survival of Osimertinib in Untreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 35-38. DOI: 10.12019/j.issn.1671-5144.2020.01.008
    Citation: HE Yong, WANG Han-min. Overall Survival of Osimertinib in Untreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 35-38. DOI: 10.12019/j.issn.1671-5144.2020.01.008
    shu

    FLAURA研究OS阳性结果——奥希替尼一线治疗晚期EGFR敏感突变非小细胞肺癌

    Overall Survival of Osimertinib in Untreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation

      摘要
      • HTML全文
      • 参考文献(7)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回